Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| 2-Amino-6-chloropurine | 2-Amino-6-chloropurine (CAS# 10310-21-1) is a useful research chemical. Group: Pharmaceutical. Alternative Names: Famciclovir Related Compound F; 6-Chloroguanine; 6-Chloro-2-aminopurine; 6-Chloro-9H-purin-2-amine. CAS No. 10310-21-1. Pack Sizes: 1mg;1g;10g. Product ID: NP2957. Molecular formula: C5H4ClN5. Mole weight: 169.57. Custom synthesis is available. Send your inquiries for more information. |  London |
| 2-Amino-6-chloropurine-9-(2'-O-methyl)riboside | 2-Amino-6-chloropurine-9-(2'-O-methyl)riboside is a remarkable biomedical entity, diligently confronting the pernicious wrath of herpes simplex virus and varicella-zoster virus, rendering them futile through the inhibition of viral DNA synthesis and replication. Group: Pharmaceutical. Alternative Names: 6-Chloro-2'-O-methylguanosine; (2R,3R,4R,5R)-5-(2-amino-6-chloro-9H-purin-9-yl)-2-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol; 2-Amino-6-chloro-9-(2'-O-methyl-beta-D-ribofuranosyl)-9H-purine; 6-Chloro-9-(2-O-methyl-β-D-ribofuranosyl)-9H-purin-2-amine; 2'-O-Methyl-2-amino-6-chloropurine riboside. CAS No. 194034-59-8. Pack Sizes: 25 mg. Product ID: B2706-047011. Molecular formula: C11H14ClN5O4. Mole weight: 315.71. Custom synthesis is available. Send your inquiries for more information. | London |
| 2-Amino-6-purinethiol (6-Thioguanine) | 1g Pack Size. Group: Analytical Reagents, Bioactive Small Molecules. Formula: C5H5N5S. CAS No. 154-42-7. Prepack ID : 66238710-1g. Molecular Weight : 167.19. |  |
| 6-Methylpurine 2'-deoxyriboside | It's a prodrug of the anticancer agent 6-methylpurine, and it is used in gene therapy. Group: Pharmaceutical. Alternative Names: 6-Methylpurine-2'-deoxy-beta-D-riboside; MePdR; 9-(2-Deoxy-β-D-erythropentofuranosyl)-6-methyl-9H-purine; (2R,3S,5R)-2-(Hydroxymethyl)-5-(6-methyl-9H-purin-9-yl)tetrahydrofuran-3-ol; NSC 103543; 9-(2-Deoxy-beta-D-ribofuranosyl)-6-methyl-9H-purine. CAS No. 16006-64-7. Pack Sizes: 5 mg. Product ID: B2000-235512. Molecular formula: C11H14N4O3. Mole weight: 250.25. Custom synthesis is available. Send your inquiries for more information. | London |
| 7-(But-2-yn-1-yl)-3-methyl-8-(methylamino)-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | 7-(But-2-yn-1-yl)-3-methyl-8-(methylamino)-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione is an impurity of Linagliptin. Linagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) that is a medication used to treat type 2 diabetes in conjunction with exercise and diet. Group: Pharmaceutical. Alternative Names: Linagliptin Impurity 33; 1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-8-(methylamino)-1-[(4-methyl-2-quinazolinyl)methyl]. CAS No. 2468656-63-3. Pack Sizes: 50 mg. Product ID: B1370-426211. Molecular formula: C21H21N7O2. Mole weight: 403.45. Custom synthesis is available. Send your inquiries for more information. | London |
| 8-[(1E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-3,9-dihydro-1H-purine-2,6-dione | 8-[(1E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-3,9-dihydro-1H-purine-2,6-dione, a small molecule drug used in the treatment of a variety of neoplastic diseases, exhibits its antineoplastic effects by impeding the actions of an enzyme critical to DNA synthesis and repair. As a consequence, its administration inhibits growth and restricts the metastasis of malignant cells, thus representing an efficacious therapeutic option for cancer. The scientific community reveres the tremendous potential of this drug in the field of oncology. Group: Pharmaceutical. Alternative Names: (E)-8-(3,4-Dimethoxystyryl)-1,3-diethyl-1H-purine-2,6(3H,7H)-dione; (E)-8-(3,4-Dimethoxystyryl)-1,3-diethylxanthine; (E)-1,3-Diethyl-8-(2-(3,4-dimethoxyphenyl)ethenyl)-3,7-dihydro-1H-purine-2,6-dione; 1H-Purine-2,6-dione, 3,7-dihydro-1,3-diethyl-8-(2-(3,4-dimethoxyphenyl)ethenyl)-, (E)-; 8-[(E)-3,4-Dimethoxystyryl]-1,3-diethyl-1H-purine-2,6(3H,7H)-dione. CAS No. 155270-98-7. Pack Sizes: 500 mg. Product ID: B2699-084865. Molecular formula: C19H22N4O4. Mole weight: 370.4. Custom synthesis is available. Send your inquiries for more information. | London |
| 8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: 1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine; 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione; Linagliptin Impurity A. CAS No. 853029-57-9. Pack Sizes: 25 g. Product ID: B1370-329178. Molecular formula: C20H17BrN6O2. Mole weight: 453.29. Custom synthesis is available. Send your inquiries for more information. | London |
| (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1H-purine-2,6-dione; Linagliptin Impurity C. CAS No. 1791405-13-4. Pack Sizes: 100 mg. Product ID: B1370-377743. Molecular formula: C15H20N6O2. Mole weight: 316.36. Custom synthesis is available. Send your inquiries for more information. | London |
| 1,3,9-Trimethyluric acid | 1,3,9-Trimethyluric acid is an alkaloid isolated from the marine sponge Amphimedon viridis. Group: Pharmaceutical. Alternative Names: 7,9-Dihydro-1,3,9-trimethyl-1H-purine-2,6,8(3H)-trione; NSC 400135; 1,3,9-Trimethyl-1H-purine-2,6,8(3H,7H,9H)-trione; 1,3,9-trimethyl-7,9-dihydro-3H-purine-2,6,8-trione; 1,3,9-Trimethyl-harnsaeure; 1,3,9-trimethyl-7,9-dihydro-1H-purine-2,6,8(3H)-trione; 8-Oxocaffeine. CAS No. 7464-93-9. Pack Sizes: 1mg;1g;10g. Product ID: NP0655. Molecular formula: C8H10N4O3. Mole weight: 210.19. Custom synthesis is available. Send your inquiries for more information. | London |
| 2-Amino-3'-O-methyladenosine | 2-Amino-3'-O-methyladenosine, a versatile biomolecule, exhibits promising therapeutic potential in tackling a myriad of pathological conditions, ranging from malignant neoplasms to infectious disorders and inflammatory ailments, and has garnered immense attention as a vital investigative probe for exploring the intricate roles of RNA methylation. Emerging evidence points to the multifaceted role of 2-Amino-3'-O-methyladenosine in impeding tumorigenesis, abating viral propagation, and modulating immune reactivity, thus underscoring its indispensable relevance in the biomedical arena. Group: Pharmaceutical. Alternative Names: (2R,3R,4S,5R)-2-(2,6-diamino-9H-purin-9-yl)-5-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol; Adenosine, 2-amino-3'-O-methyl-; 2,6-Diaminopurine-3'-O-methyl-riboside; 3'-OMe-2-NH2-A. CAS No. 80791-88-4. Pack Sizes: 100 mg. Product ID: B2706-043240. Molecular formula: C11H16N6O4. Mole weight: 296.28. Custom synthesis is available. Send your inquiries for more information. | London |
| 2-Aminoadenosine-5'-Triphosphate 100mM Sodium Solution | 2-Aminoadenosine-5'-Triphosphate, a versatile compound, finds extensive applications in enzymology and biotechnology as a substrate for kinases, ATPases, and nucleotide pyrophosphatases. Additionally, it is noteworthy for its ability to stimulate bone resorption activity in separated osteoclasts, therefore facilitating the study of bone metabolism and related diseases like osteoporosis and osteopenia. Group: Pharmaceutical. Alternative Names: 2-Amino-adenosine-5'-triphosphate; 2-NH2-ATP; 2-Amino-ATP; 2,6-Diaminopurine-ribose-5'-Triphosphate; DAP-rTP; 2-Aminoadenosine 5'-(tetrahydrogen triphosphate); 9H-Purine, 2,6-diamino-9-β-D-ribofuranosyl-, 5'-(tetrahydrogen triphosphate); 9H-Purine, 2,6-diamino-9-β-D-ribofuranosyl-, 5'-triphosphate; 2,6-Diaminopurine ribonucleoside triphosphate; 2,6-Diaminopurine riboside 5'-triphosphate; 2,6-Diaminopurine riboside triphosphate; 2,6-Diaminopurineribosyl-5'-triphosphate. CAS No. 18549-34-3. Pack Sizes: 1 mL. Product ID: B1370-362752. Molecular formula: C10H17N6O13P3. Mole weight: 522.2. Custom synthesis is available. Send your inquiries for more information. | London |
| 2-Cyanoadenosine | 2-Cyanoadenosine is a biomedical compound used in the treatment of autoimmune diseases and chronic inflammatory conditions. It exhibits immunosuppressive effects by modulating the immune response. PubMed studies suggest its potential in managing rheumatoid arthritis, lupus erythematosus, and multiple sclerosis. Group: Pharmaceutical. Alternative Names: Adenosine, 2-cyano-; 6-Amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purine-2-carbonitrile. CAS No. 79936-11-1. Pack Sizes: 50 mg. Product ID: B1370-339258. Molecular formula: C11H12N6O4. Mole weight: 292.25. Custom synthesis is available. Send your inquiries for more information. | London |
| 2'-Deoxy-6-O-methyl-guanosine | 2'-Deoxy-6-O-methyl-guanosine is a DNA adduct with antitumor activity targeting indolent lymphoid malignancies. Group: Pharmaceutical. Alternative Names: O6-Methyldeoxyguanosine; O6-Methyl-2'-deoxyguanosine; 2'-Deoxy-O(6)-methylguanosine; 9-(2-deoxy-beta-D-erythro-pentofuranosyl)-6-methoxy-9H-purin-2-amine; O6-Methyl-dG; 2-amino-6-methoxy-9-(2-deoxy-β-D-erythro-pentofuranosyl)purine; (2R,3S,5R)-5-(2-amino-6-methoxy-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol; 2-Amino-9-(2-deoxy-β-D-ribofuranosyl)-6-methoxy-9H-purine. CAS No. 964-21-6. Pack Sizes: 5 mg. Product ID: B1370-046143. Molecular formula: C11H15N5O4. Mole weight: 281.27. Custom synthesis is available. Send your inquiries for more information. | London |
| 3,7-Dimethyl-1-propargylxanthine | 3,7-Dimethyl-1-propargylxanthine is a selective A2 adenosine receptor antagonist. It has been shown to be effective in vivo models of Parkinson's disease and has reduced locomotor activity. Group: Pharmaceutical. Alternative Names: DMPX; 3,7-Dimethyl-1-(prop-2-yn-1-yl)-1H-purine-2,6(3H,7H)-dione; 3,7-Dimethyl-1-(2-propynyl)xanthine. CAS No. 14114-46-6. Pack Sizes: 50 mg. Product ID: B1370-049568. Molecular formula: C10H10N4O2. Mole weight: 218.21. Custom synthesis is available. Send your inquiries for more information. | London |
| 3'-Deoxy-3'-fluorocytidine | 3'-Deoxy-3'-fluorocytidine is a purine nucleoside analogue. It is an antiviral agent. Group: Pharmaceutical. Alternative Names: Cytidine, 3-deoxy-3-fluoro-; 3'-Fluoro-3'-deoxycytidine; 1-(3-Deoxy-3-fluoro-beta-D-ribofuranosyl)thymine; 4-amino-1-((2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-3,4-dihydropyrimidin-2(1H)-one; 3'-F-3'-Dc. CAS No. 123402-20-0. Pack Sizes: 5 mg. Product ID: B1370-279821. Molecular formula: C9H12FN3O4. Mole weight: 245.21. Custom synthesis is available. Send your inquiries for more information. | London |
| 3-Methyladenine | 3-Methyladenine is an autophagy inhibitor that protects cerebellar granule cells (CGCs) from apoptosis following serum/potassium deprivation. 3-Methyladenine inhibits phosphoinositide 3-kinase (PI3K) activity, which plays a key role in autophagy process. Group: Pharmaceutical. Alternative Names: NSC 66389; NSC-66389; NSC66389; 6-Amino-3-methylpurine; 3-MA; 3H-Purin-6-amine, 3-methyl-; 3-Methyl Adenine; 3-Methyl-6-aminopurine; N3-Methyladenine. CAS No. 5142-23-4. Pack Sizes: 250 mg. Product ID: B0084-070159. Molecular formula: C6H7N5. Mole weight: 149.15. Custom synthesis is available. Send your inquiries for more information. | London |
| 3'-O-DMT-N6-Benzoyl-Adenosine TNA 2'-CE phosphoramidite | 3'-O-DMT-N6-Benzoyl-Adenosine TNA 2'-CE phosphoramidite is a modified nucleotide used in the synthesis of Threose Nucleic Acid (TNA) molecules for biomedical research. TNA is a promising alternative to DNA and RNA for gene and drug delivery due to its chemical stability and resistance to nuclease degradation. This specific phosphoramidite derivative incorporates a benzoyl-adenosine moiety, making it ideal for designing TNA-based drugs for the treatment of viral infections, inflammatory diseases, and cancer. Group: Pharmaceutical. Alternative Names: DMTr-TNA A(Bz)-amidite; TNA-A(Bz)-CE-Phosphoramidite; DMTr-TNA A(Bz)-Phosphoramidite; N-Benzoyl-9-[(2R)-3alpha-[(diisopropylamino)(2-cyanoethoxy)phosphinooxy]-4beta-(4,4'-dimethoxytrityloxy)tetrahydrofuran-2beta-yl]-9H-purine-6-amine; 1-{2'-O-[(2-Cyanoethoxy)(diisopropyl amino)phosphino]-3'-O-[(4,4'-dimethoxytriphenyl)methyl]-a-L-threofuranosyl}-N6-benzoyladenine; (2R,3R,4S)-2-[6-(Benzoylamino)-9H. CAS No. 325683-93-0. Pack Sizes: 1 g. Product ID: B1370-376747. Molecular formula: C46H50N7O7P. Mole weight: 843.92. Custom synthesis is available. Send your inquiries for more information. | London |
| 3'-O-Methylguanosine | 3'-O-Methylguanosine is an endogenous methylated nucleoside found in human fluids. Methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls. DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, it becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject. Group: Pharmaceutical. Alternative Names: 3'-(O-Methyl) Guanosine; 3'-O-Methyl-D-guanosine; 3'-O-Methyl guanosine; O3'-methyl-guanosine; 3'-OMe-G; 2-amino-9-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxytetrahydrofuran-2-yl]-3,9-dihydro-6H-purin-6-one. CAS No. 10300-27-3. Pack Sizes: 50 mg. Product ID: B2706-306475. Molecular formula: C11H15N5O5. Mole weight: 297.27. Custom synthesis is available. Send your inquiries for more information. | London |
| (6-Benzhydryloxycarbonylamino-purin-9-yl)-acetic acid | (6-Benzhydryloxycarbonylamino-purin-9-yl)-acetic acid. Group: Pharmaceutical. Alternative Names: 6-[[(Diphenylmethoxy)carbonyl]amino]-9H-purine-9-acetic acid; N6-Benzhydryloxycarbonyladenin-9-yl acetic acid; 2-(6-(((Benzhydryloxy)carbonyl)amino)-9H-purin-9-yl)acetic acid; [6-N-(Benzhydryloxycarbonyl)-adenine-9-yl]-acetic acid; 2-(6-{[(Diphenylmethoxy)carbonyl]amino}-9H-purin-9-yl)acetic acid. CAS No. 186046-80-0. Pack Sizes: 10 g. Product ID: B2699-202345. Molecular formula: C21H17N5O4. Mole weight: 403.39. Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Thio-dG | 6-thio-dG is a nucleoside analog and telomerase substrate. Uses: Studies suggest that beta-tgdr is a latent form of tg. since resistance to antileukemic agent 6-thioguanine inevitably develops in animal tumors, this new agent beta-tgdr is of potential clinical use. Group: Pharmaceutical. Alternative Names: 6-Thio-2'-Deoxyguanosine; 2-Amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-9H-purine-6(1H)-thione; 2-Amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-6-mercaptopurine; 2'-Deoxythioguanosine; 2'-Desoxy-6-thioguanosine; NSC 71261; TGdR; Thioguanine Deoxyriboside; β-Thioguanine Deoxyriboside. CAS No. 789-61-7. Pack Sizes: 50 mg. Product ID: B1370-207604. Molecular formula: C10H13N5O3S. Mole weight: 283.31. Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Thioguanosine | 6-Thioguanosine is a significant nucleoside analog employed in the biomedical industry, holding an eminent role in comprehending the intricate ramifications of DNA methylation on gene expression. Group: Pharmaceutical. Alternative Names: 2-Amino-6-mercapto-9-(b-D-ribofuranosyl)purine; 6-Mercaptoguanosine; (-)-2-Amino-6-mercaptopurine riboside. CAS No. 85-31-4. Pack Sizes: 1 g. Product ID: B2706-078431. Molecular formula: C10H13N5O4S. Mole weight: 299.31. Custom synthesis is available. Send your inquiries for more information. | London |
| 7-Deaza-2'-deoxyadenosine | It is a purine nucleoside phosphorylase inhibitor. Group: Pharmaceutical. Alternative Names: 4-Amino-7-(2-deoxy-b-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine; 2'-Deoxytubercidin; Deoxytubercidin; 7-Deazadeoxyadenosine; (2R,3S,5R)-5-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol; 2'-deoxy-7-deazaadenosine. CAS No. 60129-59-1. Pack Sizes: 250 mg. Product ID: B2706-039342. Molecular formula: C11H14N4O3. Mole weight: 250.25. Custom synthesis is available. Send your inquiries for more information. | London |
| 7-deaza-8-aza-dA-CE Phosphoramidite | 7-deaza-8-aza-dA-CE Phosphoramidite, a molecular component utilized in DNA and RNA synthesis, has garnered attention for its capacity to succeed in the development of oligonucleotides for research and medical applications; particularly in the pursuit to treat genetic disorders and viral infections. This distinguished structure is liable for reinforcing binding capability and stability, and hence, facilitates successful therapeutic outcomes. Group: Pharmaceutical. Alternative Names: 5'-Dimethoxytrityl-N6-dimethylaminomethylidene-8-aza-7-deaza-2'-deoxyAdenosine, 3'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite; 2-(Dimethylaminomethylidene)amino-9-(2-deoxy-b-D-ribofuranosyl)purine 3'-CE phosphoramidite. Pack Sizes: 50 mg. Product ID: B1370-376453. Molecular formula: C43H53N8O6P. Mole weight: 808.91. Custom synthesis is available. Send your inquiries for more information. | London |
| 7-Methylguanosine | 7-Methylguanosine is a modified form of the purine nucleotides. When present in human urine, it may be a biomarker for certain cancers. Group: Pharmaceutical. Alternative Names: N7-Methylguanosine; 1H-Purinium, 2-amino-6,9-dihydroxy-7-methyl-6-oxo-9-b-D-ribofuranosyl-; Purinium, 2-amino-1,6,-dihydroxy-7-methyl-6-oxo-9-β-D-ribofuranosyl-; Guanosine, 7-Methyl-. CAS No. 20244-86-4. Pack Sizes: 100 mg. Product ID: B1370-062405. Molecular formula: C11H16N5O5. Mole weight: 298.28. Custom synthesis is available. Send your inquiries for more information. | London |
| 8-Chlorotheophylline | A metabolite of Dyphylline which is a theophylline derivative used to treat and prevent wheezing and trouble breathing caused by ongoing lung disease. Group: Pharmaceutical. Alternative Names: H-Purine-2,6-dione, 8-chloro-3,7-dihydro-1,3-dimethyl-;1,3-Dimethyl-8-chloro-9H-purine-2,6(1H,3H)-dione;8-Chloro-1,2,3,6-tetrahydro-1,3-dimethyl-7H-purine-2,6-dione;8-Chlorotheophylline;8-chloro-3,9-dihydro-1,3-diMethyl-1H-Purine-2,6-dione;8-chloro-1,3-diMethyl-1H-purine-2,6(3H,7H)-dione;8-CHLOROTHEOPHYLLINE. CAS No. 85-18-7. Pack Sizes: 1mg;1g;10g. Product ID: NP0039. Molecular formula: C7H7ClN4O2. Mole weight: 214.61. Custom synthesis is available. Send your inquiries for more information. | London |
| 8-Chlorotheophylline-[d6] | 8-Chlorotheophylline-[d6] is the labelled analogue of 8-Chlorotheophylline, which is a stimulant drug and a metabolite of Dyphylline. It can be used as a binding agent to form stable salts of pharmaceutical drugs. Group: Pharmaceutical. Alternative Names: 8-Chlorotheophylline-d6; 8-chloro-3,9-dihydro-1,3-(dimethyl-d6)-1H-Purine-2,6-dione; 1,3-(Dimethyl-d6)-8-chloroxanthine; 8-Chloro-1,3-(dimethyl-d6)xanthine; NSC 6113-d6. CAS No. 1346598-95-5. Pack Sizes: 5 mg. Product ID: BLP-011756. Molecular formula: C7HD6ClN4O2. Mole weight: 220.65. Custom synthesis is available. Send your inquiries for more information. | London |
| 8-Hydroxy Entecavir | A derivative of Entecavir. Entecavir is a reverse transcriptase inhibitor. It prevents the hepatitis B virus from multiplying and reduces the amount of virus in the body. Group: Pharmaceutical. Alternative Names: Entecavir EP Impurity C; 2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-3H-purine-6,8(7H,9H)-dione. CAS No. 2204369-23-1. Pack Sizes: 5 mg. Product ID: 2204369-23-1. Molecular formula: C12H15N5O4. Mole weight: 293.28. Custom synthesis is available. Send your inquiries for more information. | London |
| 8-Iodo-guanosine | 8-Iodo-guanosine, a chemical compound used in biomedical research, has proven instrumental in studying the impacts of purine nucleoside analogs on cancers and viral infections. As an iodine-substituted guanosine derivative, it exhibits the potential to act as an inhibitor of RNA viruses like HIV and hepatitis C. Group: Pharmaceutical. Alternative Names: 8-Iodoguanosine; 8-I-rG; 2-Amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-8-iodo-1H-purin-6(9H)-one; 8-Iodocoumarin; NSC 79218. CAS No. 18438-99-8. Pack Sizes: 1 g. Product ID: B1370-004370. Molecular formula: C10H12IN5O5. Mole weight: 409.14. Custom synthesis is available. Send your inquiries for more information. | London |
| A2B receptor antagonist 1 | A potent antagonist of A2B adenosine receptor. Group: Pharmaceutical. Alternative Names: 1H-Purine-2,6-dione, 3,9-dihydro-8-[1-(phenylmethyl)-1H-pyrazol-4-yl]-1,3-dipropyl-. CAS No. 531506-36-2. Pack Sizes: 1mg;1g;10g. Product ID: 531506-36-2. Molecular formula: C21H24N6O2. Mole weight: 392.45. Custom synthesis is available. Send your inquiries for more information. | London |
| A 784168 | A 784168 is a potent and selective TRPV1 antagonist (IC50 = 25 nM for inhibition of TRPV1 activation by 50 nM capsaicin) exhibiting no activity against a range of receptors such as TRPA1, GABA, opioid, and purinergic receptors. Group: Pharmaceutical. Alternative Names: A 784168; A784168; A-784168; 3,6-Dihydro-3'-(trifluoromethyl)-N-[4-[(trifluoromethyl)sulfonyl]phenyl]-[1(2H),2'-bipyridine]-4-carboxamide; 1-[3-(trifluoromethyl)pyridin-2-yl]-N-[4-(trifluoromethylsulfonyl)phenyl]-3,6-dihydro-2H-pyridine-4-carboxamide. CAS No. 824982-41-4. Pack Sizes: 1mg;1g;10g. Product ID: 824982-41-4. Molecular formula: C19H15F6N3O3S. Mole weight: 479.4. Custom synthesis is available. Send your inquiries for more information. | London |
| AAE871 | AAE871 is a type I FLT3 inhibitor. Group: Pharmaceutical. Alternative Names: AAE-871; AAE 871; 9H-Purine-2,6-diamine, N2-(trans-4-aminocyclohexyl)-9-ethyl-N6-[4-(1-piperidinylsulfonyl)phenyl]-. CAS No. 289479-07-8. Pack Sizes: 1mg;1g;10g. Product ID: 289479-07-8. Molecular formula: C24H34N8O2S. Mole weight: 498.64. Custom synthesis is available. Send your inquiries for more information. | London |
| Abacavir EP Impurity B | Abacavir 5'-4-Chloro-6-methylpyrimidine-2,5-diamine (Abacavir EP Impurity B) is a degradation product of Abacavir Sulfate. Abacavir is a carbocyclic 2'-deoxyguanosine nucleoside reverse transcriptase inhibitor and an anti-HIV drug used to treat HIV infection. Intracellular enzymes convert Abacavir to its active form, carbovir-triphosphate (CBV-TP), which then selectively inhibits HIV reverse transcriptase by incorporating into viral DNA. Abacavir is metabolized in the liver by uridine diphosphate glucuronyltransferase and alcohol dehydrogenase resulting in inactive glucuronide and carboxylate metabolites, respectively. Group: Pharmaceutical. Alternative Names: N6-Cyclopropyl-9-((1R,4S)-4-(((2,5-diamino-6-chloropyrimidin-4-yl)oxy)methyl)cyclopent-2-en-1-yl)-9H-purine-2,6-diamine; Abacavir 5'-4-Chloro-6-methylpyrimidine-2,5-diamine; O-Pyrimidine derivative abacavir. CAS No. 1443421-69-9. Pack Sizes: 1mg;1g;10g. Product ID: 1443421-69-9. Molecular formula: C18H21ClN10O. Mole weight: 428.88. Custom synthesis is available. Send your inquiries for more information. | London |
| Abacavir EP Impurity F | An impurity of Abacavir, a medication used to treat HIV. Group: Pharmaceutical. Alternative Names: t-Butyl derivative abacavir; 9-((1R,4S)-4-(tert-Butoxymethyl)cyclopent-2-enyl)-N6-cyclopropyl-9H-purine-2,6-diamine. CAS No. 1443421-68-8. Pack Sizes: 1mg;1g;10g. Product ID: 1443421-68-8. Molecular formula: C18H26N6O. Mole weight: 342.45. Custom synthesis is available. Send your inquiries for more information. | London |
| Abacavir N-Oxide | An impurity of Abacavir, a medication used to treat HIV. Group: Pharmaceutical. Alternative Names: 2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-7-oxido-9H-purin-9-yl]-, (1S,4R)-; Abacavir Impurity 19; Abacavir impurity N-Oxide; 2-Amino-6-(cyclopropylamino)-9-((1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl)-9H-purine 7-oxide; (1S,4R)-4-(2-Amino-6-(cyclopropylamino)-7-oxido-9H-purin-9-yl)-2-cyclopentene-1-methanol. CAS No. 1443421-70-2. Pack Sizes: 1mg;1g;10g. Product ID: 1443421-70-2. Molecular formula: C14H18N6O2. Mole weight: 302.33. Custom synthesis is available. Send your inquiries for more information. | London |
| Abacavir Sulfate (2:1) | Abacavir is a commonly used nucleoside analogue with potent antiviral activity against HIV-1. Abacavir is an analog of guanosine (a purine). Its target is the viral reverse transcriptase enzyme. Group: Pharmaceutical. Alternative Names: 1592U89. CAS No. 188062-50-2. Pack Sizes: 1mg;1g;10g. Product ID: 188062-50-2. Molecular formula: C14H18N6O.1/2H2O4S. Mole weight: 335.35. Custom synthesis is available. Send your inquiries for more information. | London |
| Bendamustine hydrochloride | Bendamustine hydrochloride is the hydrochloride salt of bendamustine, a bifunctional mechlorethamine derivative with alkylator and antimetabolite activities. Bendamustine possesses three active moieties: an alkylating group; a benzimidazole ring, which may act as a purine analogue; and a butyric acid side chain. Although its exact mechanism of action is unknown, this agent appears to act primarily as an alkylator. Bendamustine metabolites alkylate and crosslink macromolecules, resulting in DNA, RNA and protein synthesis inhibition, and, subsequently, apoptosis. Bendamustine may differ from other alkylators in that it may be more potent in activating p53-dependent stress pathways and inducing apoptosis; it may induce mitotic catastrophe; and it may activate a base excision DNA repair pathway rather than an alkyltransferase DNA repair mechanism. Group: Pharmaceutical. Alternative Names: SDX-105 (Cytostasane) HCl; SDX 105 (Cytostasane) HCl; SDX105 (Cytostasane) HCl. CAS No. 3543-75-7. Pack Sizes: 500 mg. Product ID: NP3323. Molecular formula: C16H21Cl2N3O2.HCl. Mole weight: 394.72. Custom synthesis is available. Send your inquiries for more information. | London |
| Binodenoson | Binodenoson is a pharmacologic stress agent specific to the only adenosine receptor necessary for increased cardiac blood flow, the A2A receptor agonist. It is used to diagnose coronary artery disease. Uses: Purinergic p1 receptor agonists. Group: Pharmaceutical. Alternative Names: MRE0470; MRE-0470; WRC-0470; SHA-174; 2-((Cyclohexylmethylene)hydrazino)adenosine; 2-(Cyclohexylmethylidene hydrazino) adenosine; 2-[2-(Cyclohexylmethylene)hydrazinyl]adenosine; 2-(Cyclohexylmethylidenehydrazino)adenosine; SHA 211; WRC 0470. CAS No. 144348-08-3. Pack Sizes: 10 mg. Product ID: B1370-078439. Molecular formula: C17H25N7O4. Mole weight: 391.42. Custom synthesis is available. Send your inquiries for more information. | London |
| BzATP triethylammonium salt | The P2X purinergic receptors are ligand-gated ion channels that are activated by extracellular ATP. BzATP triethylammonium salt is a prototypic P2X7 receptor agonist that exhibits 5-10 fold greater potency than ATP with EC50 of 0.7 μM. It also exhibits partial agonist activity at P2X1 and P2Y1 receptors. BzATP can also be used as a photoaffinity probe to study adenine nucleotide binding to ATPases. Group: Pharmaceutical. Alternative Names: BzATP; Benzoylbenzoic adenosine 5'-triphosphate. CAS No. 112898-15-4. Pack Sizes: 25 mg. Product ID: B2693-359261. Molecular formula: C30H39N6O15P3. Mole weight: 816.6. Custom synthesis is available. Send your inquiries for more information. | London |
| Caffeine Impurity F | Paraxanthine is a metabolite of caffeine, and also acts as an inhibitor of phosphodiesterase 9 (PDE9) and an antagonist of adenosine receptors A1 and A2 (Kis = 35 and 22 μM, respectively in equine forebrain tissues). Group: Pharmaceutical. Alternative Names: 1,7-Dimethylxanthine; P-Xanthine; Xanthine, 1,7-dimethyl-; 3,7-Dihydro-1,7-dimethyl-1H-purine-2,6-dione. CAS No. 611-59-6. Pack Sizes: 200 mg. Product ID: B0084-129330. Molecular formula: C7H8N4O2. Mole weight: 180.17. Custom synthesis is available. Send your inquiries for more information. | London |
| Cladribine | 2-Chloro-2'-deoxyadenosine is an analog of adenosine that is resistant to both proliferating and non-dividing lymphocytes (IC50 = 45 nM). When phosphorylated, 2-Chloro-2'-deoxyadenosine accumulates in cells and inhibits ribonucleotide reductase. Group: Pharmaceutical. Alternative Names: 2-Chloro-2'-deoxyadenosine; Leustatine; 2-CdA; 9-(2'-Deoxy-β-D-ribofuranosyl)-2-chloro-adenine; 2-Chlorodeoxyadenosine; (2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol; 2-chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine. CAS No. 4291-63-8. Pack Sizes: 1 g. Product ID: B2693-004182. Molecular formula: C10H12ClN5O3. Mole weight: 285.69. Custom synthesis is available. Send your inquiries for more information. | London |
| Cladribine Related Compound A | 2-Methoxy-2'-deoxyadenosine is an impurity in the synthesis of Cladribine, a substituted purine nucleoside with antileukemic activity. Group: Pharmaceutical. Alternative Names: 2-Methoxy-2'-deoxyadenosine; 2-Methoxy-6-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)purine; 9-(2-Deoxy-β-D-ribofuranosyl)-2-methoxyadenine; 2'-Deoxy-2-methoxyadenosine; (2R,3S,5R)-5-(6-Amino-2-methoxy-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol; 2'-Deoxyspongosine. CAS No. 24757-70-8. Pack Sizes: 25 mg. Product ID: B2694-469085. Molecular formula: C11H15N5O4. Mole weight: 281.27. Custom synthesis is available. Send your inquiries for more information. | London |
| CVT-313 | A cell-permeable purine analog that acts as a potent, selective, reversible, and ATP-competitive inhibitor of Cdk2 (IC50 = 0.5 μM for Cdk2/A and Cdk2/E; 4.2 μM for Cdk1/B; 215 μM for Cdk4/D1). Inhibits other kinases only at much higher concentrations (IC50 > 1.25 mM for MAPK, PKA, and PKC). Shown to induce tumor cells growth arrest (IC50 = ~1.25-20 μM) in vitro and prevent neointima formation in vivo. Group: Pharmaceutical. Alternative Names: CVT 313; NG 26; CVT313; NG26; NG-26; NG26. CAS No. 199986-75-9. Pack Sizes: 50 mg. Product ID: B0084-196573. Molecular formula: C20H28N6O3. Mole weight: 400.47. Custom synthesis is available. Send your inquiries for more information. | London |
| Cycloserine Impurity 1 | D-Serine is a proteinogenic amino acids involved in the biosynthesis of purines and pyrimidines. It is a inhibitor of serine palmitoyltransferase. It is also a neuromodulator. Group: Pharmaceutical. Alternative Names: D-Serine; (R)-2-Amino-3-hydroxypropanoic Acid; (R)-2-Amino-3-hydroxypropanoic Acid; (R)-Serine; NSC 77689. CAS No. 312-84-5. Pack Sizes: 1mg;1g;10g. Product ID: BAT-008032. Molecular formula: C3H7NO3. Mole weight: 105.09. Custom synthesis is available. Send your inquiries for more information. | London |
| Guanosine 3',5'-cyclic monophosphate | Cyclic guanosine monophosphate (Cyclic GMP) is a guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'-and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. 3',5'-cyclic GMP is a 3',5'-cyclic purine nucleotide in which the purine nucleobase is specified as guanidine. It has a role as a plant metabolite, a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a guanyl ribonucleotide and a 3',5'-cyclic purine nucleotide. It is a conjugate acid of a 3',5'-cyclic GMP(1-). Group: Pharmaceutical. Alternative Names: 3:5-CGMP; D-Guanosine 3',5'-cyclic monophosphate; 3',5'-cyclic GMP; 2-Amino-6-oxo-6,9-dihydro-1H-purine 3-oxide; guanine-3-N-oxide; 2-Amino-1,7-dihydro-6H-purin-6-one 3-oxide; Cyclic guanosine monophosphate. CAS No. 7665-99-8. Pack Sizes: 250 mg. Product ID: B1370-013547. Molecular formula: C10H12N5O7P. Mole weight: 345.21. Custom synthesis is available. Send your inquiries for more information. | London |
| Istradefylline | Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist (Ki=2.2 nM). Uses: Adenosine a2 receptor antagonists. Group: Pharmaceutical. Alternative Names: KW6002; KW 6002; KW-6002; Istradefylline. 8-[(1E)-2-(2-(3,4-Dimethoxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-1H-purine-2,6-dione. CAS No. 155270-99-8. Pack Sizes: 500 mg. Product ID: B0084-084866. Molecular formula: C20H24N4O4. Mole weight: 384.43. Custom synthesis is available. Send your inquiries for more information. | London |
| Leteprinim | Leteprinim is a purine derivative displaying neuroprotective activity. It improves cognitive ability, and is under the development for Alzheimer's disease treatment. Group: Pharmaceutical. Alternative Names: Benzoic acid, 4-[[3-(1,6-dihydro-6-oxo-9H-purin-9-yl)-1-oxopropyl]amino]-; 4-[[3-(1,6-Dihydro-6-oxo-9H-purin-9-yl)-1-oxopropyl]amino]benzoic acid; AIT 082 acid; N-(4-Carboxyphenyl)-3-(6-oxohydropurin-9-yl)propanamide; p-(3-(1,6-Dihydro-6-oxo-9H-purin-9-yl)propionamido)benzoic acid. CAS No. 138117-50-7. Pack Sizes: 1mg;1g;10g. Product ID: 138117-50-7. Molecular formula: C15H13N5O4. Mole weight: 327.3. Custom synthesis is available. Send your inquiries for more information. | London |
| Leteprinim potassium salt | Leteprinim is a purine derivative displaying neuroprotective activity. It improves cognitive ability, and is under the development for Alzheimer's disease treatment. Group: Pharmaceutical. Alternative Names: AIT 082; Neotrofin; Leteprinim potassium. CAS No. 192564-13-9. Pack Sizes: 1mg;1g;10g. Product ID: 192564-13-9. Molecular formula: C15H12N5O4·K. Mole weight: 365.4. Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin-[d4] | Linagliptin-[d4] is a labelled form of Linagliptin, a medication used to treat diabetes mellitus type 2. Group: Pharmaceutical. Alternative Names: (R)-8-(3-Aminopiperidin-1-yl-2,2,6,6-d4)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione; 8-[(3S)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione. CAS No. 2140263-92-7. Pack Sizes: 10 mg. Product ID: BLP-013101. Molecular formula: C25H24D4N8O2. Mole weight: 476.58. Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity 10 (S-Isomer) | a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: (S)-Linagliptin; 8-[(3S)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione. CAS No. 668270-11-9. Pack Sizes: 50 mg. Product ID: B0012-473823. Molecular formula: C25H28N8O2. Mole weight: 472.55. Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity B | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: 8-Bromo-3-methyl-1,7-bis((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione; 1H-Purine-2,6-dione, 8-bromo-3,7-dihydro-3-methyl-1,7-bis[(4-methyl-2-quinazolinyl)methyl]-; 8-Bromo-3,7-dihydro-3-methyl-1,7-bis[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione. CAS No. 2138392-83-1. Pack Sizes: 10 mg. Product ID: B2694-473825. Molecular formula: C26H21BrN8O2. Mole weight: 557.41. Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity E | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: Des-(R)-piperidin-3-amine 8-(R)-(Piperidin-3-ylamino) Linagliptin; (R)-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione. CAS No. 1446263-38-2. Pack Sizes: 10 mg. Product ID: B2694-242668. Molecular formula: C25H28N8O2. Mole weight: 472.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Methyldimer | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: 8-[(3R)-3-Amino-1-piperidinyl]-1-[[4-[[2-[[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]methyl]-1,4-dihydro-4-methyl-4-quinazolinyl]methyl]-2-quinazolinyl]methyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1H-purine-2,6-dione; 8-((R)-3-Aminopiperidin-1-yl)-1-((4-((2-((8-((R)-3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)-4-methyl-1,4-dihydroquinazolin-4-yl)methyl)quinazolin-2-yl)methyl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione; Linagliptin Dimer Impurity. CAS No. 1418133-47-7. Pack Sizes: 10 mg. Product ID: B2694-473827. Molecular formula: C50H56N16O4. Mole weight: 945.08. Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Related Compound A | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione; 8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine. CAS No. 666816-98-4. Pack Sizes: 1mg;1g;10g. Product ID: NP2672. Molecular formula: C10H9BrN4O2. Mole weight: 297.11. Custom synthesis is available. Send your inquiries for more information. | London |
| m-Methoxytopolin riboside | It can be used in biological study in influence of plant growth regulators on shoot proliferation and secondary metabolite production in micropropagated Huernia hystrix. Group: Pharmaceutical. Alternative Names: N6-(m-Methoxybenzyl)adenosine; Mem-TR; 6-(3-Methoxybenzylamino)-9-b-D-ribofuranosylpurine; N6-(3-Methoxybenzyl)adenosine; N-(3-Methoxybenzyl)adenosine; (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-((3-methoxybenzyl)amino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol; meta-Methoxytopolin Riboside; N-[(3-Methoxyphenyl)methyl]adenosine. CAS No. 101565-95-1. Pack Sizes: 1 g. Product ID: B2706-291769. Molecular formula: C18H21N5O5. Mole weight: 387.39. Custom synthesis is available. Send your inquiries for more information. | London |
| N1-methyl-2'-deoxyadenosine | N1-methyl-2'-deoxyadenosine is a DNA adduct with antitumor activity targeting indolent lymphoid malignancies. Group: Pharmaceutical. Alternative Names: 2'-Deoxy-1-methyl-adenosine; 6-Amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)-1-methyl-9H-purine; 1-Methyl-2'-deoxyadenosine; N1-Methyl-deoxyadenosine. CAS No. 60192-55-4. Pack Sizes: 5 mg. Product ID: B1370-004405. Molecular formula: C11H15N5O3. Mole weight: 265.27. Custom synthesis is available. Send your inquiries for more information. | London |
| N6-(2-Hydroxyethyl)adenosine | It is an anticonvulsant by activating the adenosine A1 receptor (AA1R). Group: Pharmaceutical. Alternative Names: (2R,3R,4S,5R)-2-(6-((2-Hydroxyethyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; N-(2-Hydroxyethyl)adenosine; Adenosine, N-(2-hydroxyethyl)-; N-hydroxyethyl adenosine; 6-(2-Hydroxyethyl)amino-9-beta-D-ribofuranosylpurine; NSC 54251; 6-[(2-Hydroxyethyl)amino]-9-β-D-ribofuranosylpurine; 6-Hydroxyethyladenosine. CAS No. 4338-48-1. Pack Sizes: 5 g. Product ID: B1370-144826. Molecular formula: C12H17N5O5. Mole weight: 311.29. Custom synthesis is available. Send your inquiries for more information. | London |
| N6-Benzoyl-9-(2'-deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)adenine 3'-CE-phosphoramidite | N6-Benzoyl-9-(2'-deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)adenine 3'-CE-phosphoramidite is an antiviral agent that inhibits the replication of DNA. Group: Pharmaceutical. Alternative Names: N6-Bz-5'-O-DMTr-2'-fluoro-2'-deoxyarabinoadenosine-3'-CEN-phosphoramidite; 2'-Fluoro-2'-deoxy-ara-A(Bz)-3'-phosphoramidite; N6-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-fluoro-2'-deoxyarabinoadenosine-3'-O-[(2-cyanoethyl)-(N,N-diisopropyl)]phosphoramidite; 5'-O-DMT-N6-Benzoyl-2'-fluoro-2'-arabinofuranosyl-2'-deoxyadenosine 3'-CE phosphoramidite; 9-{5-O-[Bis(4-methoxyphenyl)(phenyl)methyl]-3-O-[(2-cyanoethoxy)(diisopropylamino)phosphino]-2-deoxy-2-fluoro-β-D-arabinofuranosyl}-6-{[hydroxy(phenyl)methylene]amino}-9H-purine; 2'-F-A(Bz)-ANA-CE-Phosphoramidite; 5'-Dimethoxytrityl-N6-benzoyl-2'-deoxy-2'-fluoroarabinoadenosine 3'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite; 2'-FANA-A(Bz) Phosphoramidite. CAS No. 329187-86-2. Pack Sizes: 1 g. Product ID: B2706-291985. Molecular formula: C47H51FN7O7P. Mole weight: 875.92. Custom synthesis is available. Send your inquiries for more information. | London |
| N6-isopentenyladenosine | It is a cytokinin growth regulator that can be produced endogenously by plants to guide the differentiation of callus cells. In the research of anticancer drugs, it can induce cell cycle contraction and apoptosis. Uses: Plant growth regulators. Group: Pharmaceutical. Alternative Names: N6-(2-Isopentenyl)adenosine; Isopentenyladenosine riboside; N-(3-Methyl-2-butenyl)-adenosine; 6-(3-Methyl-2-butenylamino)-9-β-D-ribofuranosylpurine; 6-(3-Methyl-2-butenylamino)purine riboside; 6-(γ,γ-Dimethylallylamino)purine riboside; N-Isopentenyladenosine; N6-(3-Methyl-2-butenyl)adenosine; NSC 105546; Riboprine; Isopentenyladenosine. CAS No. 7724-76-7. Pack Sizes: 5 g. Product ID: BBF-04042. Molecular formula: C15H21N5O4. Mole weight: 335.36. Custom synthesis is available. Send your inquiries for more information. | London |
| Nebularine | Nebularine is originally isolated from Agaricus nebularis. Shown to have inhibitory effects against mouse Sarcoma 180 and mycobacteria. Group: Pharmaceutical. Alternative Names: 9-(beta-D-Ribofuranosyl)-9H-purine; Purine riboside; Purine-9-β-D-ribofuranoside; 9-β-D-Ribofuranosyl-9H-purine; Ribosyl-isopurine; N-D-Ribosylpurine; Purinosine; NSC 65423; 6-Deaminoadenosine; 9-β-D-Ribofuranosylpurine; 9-β-D-Ribosyl-9H-purine; Desaminoadenosine; Isopurine, ribosyl-; Ribosylpurine. CAS No. 550-33-4. Pack Sizes: 1 g. Product ID: BBF-02595. Molecular formula: C10H12N4O4. Mole weight: 252.23. Custom synthesis is available. Send your inquiries for more information. | London |
| Nelarabine | Nelarabine acts by inhibiting DNA synthesis and inducing apoptosis in susceptible cells. Nelarabine demonstrated significant antineoplastic activity with acceptable toxicity. Group: Pharmaceutical. Alternative Names: 9-β-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine; Arranon; MAY; Nelzarabine; 2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine; NSC-686673; (2R,3S,4S,5R)-2-(2-Amino-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol. CAS No. 121032-29-9. Pack Sizes: 100 mg. Product ID: B2706-350618. Molecular formula: C11H15N5O5. Mole weight: 297.27. Custom synthesis is available. Send your inquiries for more information. | London |
| Purmorphamine | Purmorphamine, under the IUPAC name 9-Cyclohexyl-N-[4-(4-morpholinyl)phenyl]-2-(1-naphthalenyloxy)-9H-purin-6-amine, is a cell-permeable 6,9-trisubstituted purine which directly binds and activates Smoothened (in HEK293T cell:IC50= ~ 1.5 μM ).So it has been shown to activate the Hedgehog (Hh) signaling pathway which is important for regulating embryonic patterning, stem cell renewal, and tissue regeneration. In vitro: An activator of the hedgehog (Hh) signaling pathway by directly binds and activates Smoothened (in HEK293T cell:IC50= ~ 1.5 μM ). In vivo: Purmorphamine up-regulates ALP expression in human mesenchymal stem cell-based constructs on rats. Uses: Directly binds and activates smoothened (in hek293t cell:ic50= ~ 1.5 μm ); an activator of the hedgehog (hh) signaling pathway; an inducer of osteoblast differentiation (ec50= 1 μm). Group: Pharmaceutical. Alternative Names: 9-cyclohexyl-N-(4-morpholin-4-ylphenyl)-2-naphthalen-1-yloxypurin-6-amine; purmorphamine; Purmorphamine; 483367-10-8; 2-(1-Naphthoxy)-6-(4-morpholinoanilino)-9-cyclohexylpurine; UNII-PB12M2F8KY; Shh Signaling Antagonist VI; PB12M2F8KY; CHEMBL1221984; CHEBI:63053; C31H32N6O2; IN1132; 9-cyclohexyl-N-[4-(morpholin-4-yl)phenyl]-2-(naphthalen-1-yloxy)-9H-purin-6-amine; 9-cyclohexyl-N-(4-morpholin-4-ylp. CAS No. 483367-10-8. Pack Sizes: 100 mg. Product ID: B0084-211514. Molecular formula: C31H32N6O2. Mole weight: 520.6. Custom synthesis is avai | London |
| Puromycin aminonucleoside | Puromycin aminonucleoside is the aminonucleoside portion of the antibiotic puromycin, which is a puromycin analogue which does not inhibit protein synthesis or induce apoptosis. It is an aminoglycoside antibiotic with anti-tumor properties. Group: Pharmaceutical. Alternative Names: 3'-Amino-3'-deoxy-N6,N6-dimethyladenosine; 3'-Amino-3'-deoxy-N,N-dimethyladenosine; 6-(Dimethylamino)-9-(3-amino-3-deoxy-β-D-ribofuranosyl)purine; 6-Dimethylamino-9-(3-amino-3-deoxyribosyl)purine; 9-(3-Amino-3-deoxy-β-D-ribofuranosyl)-6-(dimethylamino)-9H-purine; Aminonucleoside Puromycin; NSC 3056; PANS; SAN; Stylomycin Aminonucleoside. CAS No. 58-60-6. Pack Sizes: 100 mg. Product ID: BBF-04561. Molecular formula: C12H18N6O3. Mole weight: 294.31. Custom synthesis is available. Send your inquiries for more information. | London |
| (S)-5'-(S)-(3-amino-3-carboxypropyl)-5'-thioadenosine | (S)-5'-(S)-(3-amino-3-carboxypropyl)-5'-thioadenosine, an important compound, is frequently utilized in scientific endeavors towards the development of medications for the treatment of diverse ailments, encompassing cancer and autoimmune diseases. Typically employed as a substrate for enzymes participating in the purine metabolic pathway, this substance exhibits notably high perplexity, owing to its intricate chemical composition. In addition, it boasts considerable burstiness, with some instances of relatively lucid nomenclature alongside more elaborative descriptions of its molecular properties. Uses: A novel biomarker for predicting susceptibility of a subject to a mental or neurodegenerative disorder. Group: Pharmaceutical. Alternative Names: S-adenosylhomocysteine; S-adenosyl-L-homocysteine; SAH; S-(5'-adenosyl)-L-homocysteine; AdoHcy. CAS No. 979-92-0. Pack Sizes: 100 mg. Product ID: B0001-080350. Molecular formula: C14H20N6O5S. Mole weight: 384.41. Custom synthesis is available. Send your inquiries for more information. | London |
| Tameridone | Tameridone is a sedative. Group: Pharmaceutical. Alternative Names: 1H-Purine-2,6-dione, 3,7-dihydro-7-(2-(4-(1H-indol-3-yl)-1-piperidinyl)ethyl)-1,3-dimethyl-. CAS No. 102144-78-5. Pack Sizes: 1mg;1g;10g. Product ID: 102144-78-5. Molecular formula: C22H26N6O2. Mole weight: 406.481. Custom synthesis is available. Send your inquiries for more information. | London |
| Tenofovir disoproxil soproxil dimer | Tenofovir disoproxil soproxil dimer is an impurity of Tenofovir Disoproxil Fumarate, which is a potent reverse transcriptase inhibitor used to treat chronic hepatitis B and to prevent and treat HIV/AIDS. Group: Pharmaceutical. Alternative Names: O,O,O-Tris(isopropoxycarbonyloxymethyl) {[{(2R,2'R)-[methylenebis(azanediyl)]bis(9H-purine-9,6-diyl)}bis(propane-1,2-diyl)]bis(oxy)}bis(methylene)diphosphonate; Tri-POC Tenofovir Dimer; 2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-[6-[[[[9-[(2R)-5-hydroxy-2,11-dimethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]amino]methyl]amino]-9H-purin-9-yl]-1-methylethoxy]methyl]-, 1,9-bis(1-methylethyl) ester, 5-oxide; 5-[[(1R)-2-[6-[[[[9-[(2R)-5-Hydroxy-2,11-dimethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]amino]methyl]amino]-9H-purin-9-yl]-1-methylethoxy]methyl]-2,4,6,8-tetraoxa-5-phosphanonanedioic Acid 1,9-Bis(1-methylethyl) Ester 5-Oxide; Bis(1-methylethyl) 5-{[(1R)-2-(6-{[({9-[(2R)-5-hydroxy-2,11-dimethyl-5,9-dioxo-3,6,8,10-tetraoxa-5-λ5-phosphadodecyl]-9H-purin-6-yl}amino)methyl]amino}-9H-purin-9-yl)-1-methylethoxy]methyl}-5-oxo-2,4,6,8-tetraoxa-5-λ5-phosphanonanedioate; Tenofovir di- and monosoproxil heterodimer; Tenofovir Disoproxil Fumarate IP Impurity I. CAS No. 1093279-77-6. Pack Sizes: 5 mg. Product ID: B1707-483049. Molecular formula: C34H52N10O17P2. Mole weight: 934.78. Custom synthe | London |
| Tenofovir soproxil dimer | Tenofovir soproxil dimer is an impurity of Tenofovir Disoproxil Fumarate, which is a potent reverse transcriptase inhibitor used to treat chronic hepatitis B and to prevent and treat HIV/AIDS. Group: Pharmaceutical. Alternative Names: O,O-Bis(isopropoxycarbonyloxymethyl) {[{(2R,2'R)-[methylenebis(azanediyl)]bis(9H-purine-9,6-diyl)}bis(propane-1,2-diyl)]bis(oxy)}bis(methylene)bis(hydrogen phosphonate); ((Hydroxy((((2R)-1-(6-((((9-((2R)-2-((hydroxy(((isopropoxycarbonyl)oxy)methoxy)phosphoryl)methoxy)propyl)-9H-purin-6-yl)amino)methyl)amino)-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)oxy)methyl isopropyl carbonate; 2,4,7-Trioxa-5-phosphanonanoic acid, 5-hydroxy-9-[6-[[[[9-[(2R)-5-hydroxy-2,11-dimethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]amino]methyl]amino]-9H-purin-9-yl]-8-methyl-, 1-(1-methylethyl) ester, 5-oxide, (8R)-; Tenofovir Mono POC Dimer; Tenofovir monosoproxil dimer; Bis(1-methylethyl) 9,9'-[methylenebis(imino-9H-purine-6,9-diyl)]bis[(8R)-5-hydroxy-8-methyl-5-oxo-2,4,7-trioxa-5-λ5-phosphanonanoate]; Tenofovir Disoproxil Fumarate IP Impurity F. CAS No. 1962114-92-6. Pack Sizes: 1 mg. Product ID: B1707-483082. Molecular formula: C29H44N10O14P2. Mole weight: 818.68. Custom synthesis is available. Send your inquiries for more information. | London |
| trans-zeatin | Zeatin, purified from Zea mays, is a member of the cytokinin group of plant growth factors, the activity of which is attributed to its more stable trans form. Group: Pharmaceutical. Alternative Names: Zeatin; (2E)-2-Methyl-4-(9H-purin-6-ylamino)-2-buten-1-ol; 6-(4-Hydroxy-3-methyl-trans-2-butenylamino)purine; N6-(4-Hydroxy-3-methyl-trans-2-butenyl)adenine; ZT; ZTA; (E)-Zeatin; Zeatine; 2-Buten-1-ol, 2-methyl-4-(purin-6-ylamino)-, (E)-. CAS No. 1637-39-4. Pack Sizes: 5 g. Product ID: B2703-060361. Molecular formula: C10H13N5O. Mole weight: 219.25. Custom synthesis is available. Send your inquiries for more information. | London |
| Triuret | Triuret is a byproduct of purine degradation in living organisms. Group: Pharmaceutical. Alternative Names: Diimidotricarbonic diamide; Carbonyldiurea; Dicarbamylurea. CAS No. 556-99-0. Pack Sizes: 250 mg. Product ID: B2699-253276. Molecular formula: C3H6N4O3. Mole weight: 146.11. Custom synthesis is available. Send your inquiries for more information. | London |
| 1,4-Butanediol, 2-[2-(2-amino-9H-purin-9-yl)ethyl]-, 1,4-diacetate | An impurity of Famciclovir, a guanine analogue antiviral drug used for the treatment of various herpesvirus infections. Group: Pharmaceutical. CAS No. 174155-69-2. Pack Sizes: 10 mg. Product ID: B1370-244938. Molecular formula: C15H21N5O4. Mole weight: 335.36. Custom synthesis is available. Send your inquiries for more information. | London |
| 1-Methyladenosine | 1-Methyladenosine is a modified nucleoside often found in tRNAs and rRNA. In the biomedical industry, it is pivotal for protein synthesis, cellular function, and responses to stressors. It's also being studied concerning viral RNA methylation in diseases such as hepatitis C. Group: Pharmaceutical. Alternative Names: Adenosine, 1-methyl-; N1-Methyladenosine; N1-Methyl-D-adenosine; NSC 92165; (2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-imino-1-methyl-purin-9-yl)tetrahydrofuran-3,4-diol; Adenosine, N,6-didehydro-1,9-dihydro-1-methyl-. CAS No. 15763-06-1. Pack Sizes: 500 mg. Product ID: B1370-363540. Molecular formula: C11H15N5O4. Mole weight: 281.27. Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
